Jeffrey Allen Morris serves as Executive at PROVECTUS BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Jeffrey Allen Morris has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 12, 2024 involved exercising options for 264,314 shares valued at $755.9K.
Jeffrey Allen Morris currently holds 4,260,061 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Allen Morris has been a net neutral trader of PVCT stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey Allen Morris's most recent insider trade was on Aug 12, 2024, when they sold 264,314 shares at $2.86 per share.
Get notified when new Form 4 filings are submitted
| 188,757 |
| $2.86 |
| Discretionary |